Morocco: Pharmaceutical company Laprophan opens capital to a consortium of investors

Friday, 24 February 2023 15:47
Morocco: Pharmaceutical company Laprophan opens capital to a consortium of investors

(Ecofin Agency) - The leading pharmaceutical company Laprophan is set to receive an investment of approximately $71.9 million for a minority stake in its capital. The transaction led by Mediterrania Capital Partners is subject to the usual regulatory approvals.

For the first time since its creation some 70 years ago, family-owned pharmaceutical company Laprophan will open its capital to foreign investors. Last Tuesday, the company announced an investment protocol with private equity firm Mediterrania Capital Partners and private sector financing institution Proparco and development finance institutions FMO and DEG.

Under the protocol, the consortium of investors will disburse MAD750 million ($71.9 million) for a minority stake in Laprophan. The deal still needs to obtain the usual regulatory approvals, including those of Morocco's Competition Authority. 

The funds will allow Laprophan to expand its business in Morocco, offering new products and also boosting its export capabilities. Farid Bennis, General Manager of Laprophan, stressed that this agreement should help meet the Kingdom's public health needs while strengthening Laprophan's international positions.

Chamberline Moko



Public Management

ECOFIN AGENCY offers a selection of articles translated from AGENCE ECOFIN. Founded in 2011, Agence Ecofin is a leader in Francophone Pan-African economic news, particularly in West and Central Africa. The agency publishes daily news on nine African economic sectors: Public Management, Finance, ICT, Agribusiness, Energy, Mining, Transport & Logistics, Communication, and Training.

Mediamania Sarl
Rue du Léman, 6
1201 Genève
Tél: +41 22 301 96 11


Benjamin FLAUX
Tél: +41 22 301 96 11
Mob: +41 78 699 13 72


Please publish modules in offcanvas position.